Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Establishment of Anti-Human ATRX Monoclonal Antibody AMab-6.

Ogasawara S, Fujii Y, Kaneko MK, Oki H, Sabit H, Nakada M, Suzuki H, Ichimura K, Komori T, Kato Y.

Monoclon Antib Immunodiagn Immunother. 2016 Oct;35(5):254-258.

2.

Immunohistochemistry using monoclonal antibody MsMab-2 is useful to detect IDH1 R132L in intrahepatic cholangiocarcinoma.

Hayashi A, Misumi K, Shibahara J, Kokudo N, Kato Y, Fukayama M.

Pathol Int. 2016 Oct;66(10):578-582. doi: 10.1111/pin.12459. Epub 2016 Sep 5.

PMID:
27595804
3.

Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas.

Kato Y.

Brain Tumor Pathol. 2015 Jan;32(1):3-11. doi: 10.1007/s10014-014-0202-4. Epub 2014 Oct 17. Review.

PMID:
25324168
4.

Monoclonal antibody MsMab-2 against mutated IDH1 and IDH2.

[No authors listed]

Monoclon Antib Immunodiagn Immunother. 2013 Dec;32(6):430. doi: 10.1089/mab.2013.0054. No abstract available.

PMID:
24328751
5.

Multi-specific monoclonal antibody MsMab-2 recognizes IDH1-R132L and IDH2-R172M mutations.

Ogasawara S, Kaneko MK, Tsujimoto Y, Liu X, Kato Y.

Monoclon Antib Immunodiagn Immunother. 2013 Dec;32(6):377-81. doi: 10.1089/mab.2013.0050.

PMID:
24328739

Supplemental Content

Loading ...
Support Center